Other OTC - Delayed Quote USD

PD-Rx Pharmaceuticals, Inc. (PDRX)

0.0000 -4.9100 (-100.00%)
At close: March 26 at 1:45 PM EDT
Loading Chart for PDRX
DELL
  • Previous Close 4.9100
  • Open 4.8900
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 7.5000
  • Volume 1,771
  • Avg. Volume 14
  • Market Cap (intraday) 1
  • Beta (5Y Monthly) -0.07
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 1.0800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 13, 2018
  • 1y Target Est --

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company provides approximately 2,600 prepackaged medications; and creams, ointments, ophthalmics, otics, liquids, suspensions, etc. It also offers PD-Rx Net, a web-based application that tracks prescriptions filled at the point of care and print prescription labels for prescription that filled onsite; and manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a convenient handling package. In addition, the company provides professional assistance by staffed pharmacists and physicians; and pharmaceutical sampling program design to reduce MCO's pharmaceutical costs, as well as allows medical professionals to offer pre-filled prescriptions to patients free of charge. It serves physicians, pharmacies, and medical clinics. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma.

www.pdrx.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PDRX

Performance Overview: PDRX

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PDRX
100.00%
S&P 500
11.18%

1-Year Return

PDRX
100.00%
S&P 500
29.04%

3-Year Return

PDRX
100.00%
S&P 500
27.06%

5-Year Return

PDRX
100.00%
S&P 500
84.38%

Compare To: PDRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PDRX

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.46%

  • Return on Assets (ttm)

    -0.91%

  • Return on Equity (ttm)

    -0.87%

  • Revenue (ttm)

    21.27M

  • Net Income Avi to Common (ttm)

    -98.06k

  • Diluted EPS (ttm)

    1.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    104.55k

  • Total Debt/Equity (mrq)

    31.31%

  • Levered Free Cash Flow (ttm)

    1.38M

Research Analysis: PDRX

Company Insights: PDRX

Research Reports: PDRX

People Also Watch